Disclosure Panels Details Page
Hematopoietic Cell Transplantation Panel - Disclosures as of 09/12/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Marian Birkeland PhD | None | None | None | None | - |
| Nicole Blankenhorn | None | None | None | None | - |
| Javier Bolaños-Meade MD | None | None | None | None | ✔ |
| George Chen MD | Actinium AlloVIr Equillium Genentech, Inc. |
None | None | None | - |
| Meredith Cowden MA | None | None | Incyte Corporation | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | ✔ |
| Antonio Di Stasi MD | None | None | Syndax pharmaceutical | None | - |
| Mary Dwyer MS | None | None | None | None | - |
| Areej El-Jawahri MD | None | AIM pathway GSK Novartis Pharmaceuticals Corporation |
None | None | - |
| Hany Elmariah MD, MS | Bristol Myers Squibb | None | None | None | ✔ |
| Sherif Farag MD, PhD, FACP | None | None | None | None | - |
| Meghan Fay BSN, RN, OCN | None | None | None | None | - |
| Tanya Fischer MEd, MLIS | None | None | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Krishna Gundabolu MBBS, MS, FACP | None | Blueprint Medicines Bristol Myers Squibb CTI BioPharma Corp. sanofi-aventis U.S. Spark Therapeutics |
None | Stock in Geron | - |
| Jonathan Gutman MD | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Erin Hesler | None | None | None | None | - |
| Vincent Ho MD | allovir Jazz Pharmaceuticals Inc. Omeros |
Alexion Pharmaceuticals, Inc. Omeros LLC |
Alexion Pharmaceuticals, Inc. Omeros, LLC |
None | ✔ |
| Rasmus Hoeg MD | None | None | None | None | ✔ |
| Mitchell Horwitz MD | AbbVie, Inc. Allovir CSL Behring Equillium Gamida Cell Incyte Corporation Kadmon magenta Talaris |
Allovir Talaris |
None | None | ✔ |
| Samantha Jaglowski MD, MPH | Bristol Myers Squibb CRISPR Therapeutics Kite Pharma Novartis Pharmaceuticals Corporation |
Cardinal Health Caribou Kite Pharma |
None | None | ✔ |
| Frankie Jones | None | None | None | None | ✔ |
| Madeline Joyce BSN, RN, OCN | None | None | None | None | - |
| Adetola Kassim MD, MS | None | None | None | None | - |
| Mohamed Kharfan Dabaja MD | Bristol Myers Squibb Novartis Pharmaceuticals Corporation Pharmacyclics |
None | None | None | ✔ |
| Alison Loren MD, MSCE | Equillium | None | None | American Society of Hematology | ✔ |
| John Magenau MD | Merck & Co., Inc. | None | None | None | ✔ |
| Thomas Martin MD | Amgen Inc. Bristol Myers Squibb Janssen Pharmaceutica Products, LP sanofi-aventis U.S. |
Eli Lilly and Company GSK Pfizer Inc. |
Legend Biotech | None | ✔ |
| Marco Mielcarek MD | None | None | None | None | ✔ |
| Jonathan Moreira MD | None | IngenioRx Kite Pharma |
None | None | - |
| Lori Muffly MD | Adaptive Astellas Pharma US, Inc. Bristol Myers Squibb Jasper Kite Pharma |
Adaptive Amgen Inc. Astellas Pharma US, Inc. Autolus Kite Pharma Pfizer Inc. |
None | None | ✔ |
| Ryotaro Nakamura MD | Helocyte Miyarisan |
bluebird NapaJen Pharma Omeros sanofi-aventis U.S. |
None | None | ✔ |
| Yago Nieto MD, PhD | Affimed AstraZeneca Pharmaceuticals LP Secura Bio Inc |
None | None | None | ✔ |
| Cameron Ninos PharmD | None | None | None | None | ✔ |
| Caspian Oliai MD | Amgen Inc. Genentech, Inc. Jazz Pharmaceuticals Inc. Kiadis Novartis Pharmaceuticals Corporation Ono Orca Pfizer Inc. |
None | None | None | - |
| Genovefa Papanicolaou MD | NA | NA | NA | NA | ✔ |
| Seema Patel PharmD | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Brion Randolph MD | None | None | Bristol Myers Squibb | None | ✔ |
| Mark Schroeder MD | Ichnos Sciences SA Incyte Corporation Janssen Pharmaceutica Products, LP Kura Oncology (through IQVIA CRO) Marker Therapeutics (through Advarra CRO) Sorrento (through Advarra CRO) Takeda Pharmaceuticals North America, Inc. |
None | Advarra CRO - DSMB board for Marker and Sorrento Therapeutics IQVIA CRO- endpoint adjudication for Novo Nordisk trials Parexel CRO - Endpoint adjudication for GSK trials |
None | ✔ |
| Katie Stehman MMS, PA-C | None | None | None | None | ✔ |
| Jeffrey Topal MD | None | None | None | None | - |
| Dimitrios Tzachanis MD, PhD | Autolus Bristol Myers Squibb Genentech, Inc. Incyte Corporation Kite Pharma |
None | None | None | ✔ |
| Asya Nina Varshavsky-Yanovsky MD, PhD | AbbVie, Inc. Bristol Myers Squibb Gilead Sciences, Inc. GSK Pfizer Inc. Takeda Pharmaceuticals North America, Inc. |
Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP Pfizer Inc. |
None | None | ✔ |